X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Medicare Monday: What you need to know about the latest Medicare Trustees report

By Nicole Longo  |    July 17, 2017
Last week, the Trustees of the Social Security and Medicare trust funds released its annual report on the current and projected financial status of Medicare. Here are a few important takeaways in...   Read More

Medicare Monday: Study finds mortality rates for elderly have decreased every year since creation of Part D

By Nicole Longo  |    July 10, 2017
On Medicare Monday, we’ve talked about how Medicare Part D’s competitive structure improves access to affordable prescription drug coverage for seniors and individuals with disabilities. We’ve...   Read More

Medicare Monday: It is Medicare’s birthday month!

By Nicole Longo  |    July 3, 2017
On July 30, 1965, Medicare was signed into law by President Lyndon B. Johnson, so this week we’re kicking off Medicare’s birthday month with a look back at some of our favorite resources.   Read More

Medicare Monday: 3 reasons why repealing Part D’s noninterference clause is a bad idea

By Nicole Longo  |    June 26, 2017
A number of proposals have been thrown around as part of the health care debate. One idea is to repeal the noninterference clause in Medicare Part D. Doing so would allow the Secretary of Health...   Read More

Medicare Monday: How government price setting in Part D could reduce innovation, shorten life expectancy for beneficiaries

By Nicole Longo  |    June 19, 2017
Today, we are diving into the conversation about how government price setting proposals could impact the Medicare Part D program and beneficiaries. Imposing Veterans Administration (VA)-style...   Read More

Medicare Monday: New report highlights progress in fighting cancer with new physician-administered medicines

By Nicole Longo  |    June 12, 2017
We’ve seen significant progress in recent years in the treatment of cancer, and that progress is expected to continue. A new report released this month found that there are more than 240 new...   Read More

Medicare Monday: Positive impact of Part D on America’s seniors

By Nicole Longo  |    June 5, 2017
Implementation of Medicare Part D significantly increased access to medicines for seniors and for those under age 65 with permanent disabilities. Since then, Part D has contributed to significant...   Read More

Medicare Monday: Catch up on MedPAC and its Part B recommendations

By Nicole Longo  |    May 29, 2017
A long weekend is the perfect time to catch up on your reading list. For policy wonks, you can get up to speed with our Memorial Day reading list on the Medicare Payment Advisory Commission...   Read More

Medicare Monday: Did you know Medicare Part B uses a market-based system to pay for medicines?

By Nicole Longo  |    May 22, 2017
We often discuss the creation of Part D when we talk about the market-based changes that the Medicare Modernization Act (MMA) made to Medicare, but that’s just one example. Today, let’s take a...   Read More

Medicare Monday: Why imposing Medicaid-style rebates in Part D is a bad idea

By Nicole Longo  |    May 15, 2017
We’ve talked a lot about how repealing the non-interference clause in Medicare Part D would negatively impact beneficiaries. But there are other proposals to fundamentally alter the structure of...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates